WHO ICTRP trial
The DRIP Trial
ACTRN12605000147684 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12605000147684 |
|---|---|
| Public title | The DRIP Trial |
| Scientific title | A randomised phase III study to evaluate the effects of changing peripheral intravenous cannulas when clinically indicated to reduce the rate of cannula related complications |
| Primary sponsor | Joan Webster |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 / Phase 3 |
| Countries | Australia |
| Conditions | Phlebitis and other adverse outcomes of peripheral venous cannulation.; Phlebitis and other adverse outcomes of peripheral venous cannulation.;Inflammatory and Immune System - Rheumatoid arthritis |
| Interventions | Intervention: Cannula re-sited when clinically indicated |
| Registration date | Aug 15, 2005 |
| Target size | 754 |
| Secondary IDs | [email protected] |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: